Previous Article | Next Article 
J Bacteriol, February 1998, p. 473-477, Vol. 180, No. 3
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutational Analysis of UMP Kinase from
Escherichia coli
Nadia
Bucurenci,1
Lidia
Serina,2
Cristina
Zaharia,1
Stéphanie
Landais,3
Antoine
Danchin,4 and
Octavian
Bârzu2,*
Institute Cantacuzino, 70100 Bucharest,
Romania,1 and
Laboratoire de Chimie
Structurale des Macromolécules,2
Laboratoire de l'Hybridolab,3 and
Unité de Régulation de l'Expression
Génétique,4 Institut
Pasteur, 75724 Paris Cedex 15, France
Received 13 October 1997/Accepted 20 November 1997
 |
ABSTRACT |
UMP kinase from Escherichia coli is one of the four
regulatory enzymes involved in the de novo biosynthetic pathway of
pyrimidine nucleotides. This homohexamer, with no counterpart in
eukarya, might serve as a target for new antibacterial drugs. Although the bacterial enzyme does not show sequence similarity with any other
known nucleoside monophosphate kinase, two segments between amino acids
35 to 78 and 145 to 194 exhibit 28% identity with phosphoglycerate
kinase and 30% identity with aspartokinase, respectively. Based on
these similarities, a number of residues of E. coli UMP kinase were selected for site-directed mutagenesis experiments. Biochemical, kinetic, and spectroscopic analysis of the modified proteins identified residues essential for catalysis (Asp146), binding
of UMP (Asp174), and interaction with the allosteric effectors, GTP and
UTP (Arg62 and Asp77).
 |
INTRODUCTION |
Nucleoside monophosphate (NMP)
kinases are ubiquitous enzymes in all forms of living cells, and they
represent a homologous family of proteins with structural and catalytic
properties similar to those of adenylate kinases (4, 7, 9).
UMP kinase from Escherichia coli is a noticeable exception
to this paradigm. The protein, encoded by the pyrH gene
(16), does not show sequence similarity with any other known
NMP kinase, has an oligomeric structure, and is subjected to complex
regulatory mechanism in which UTP and GTP act as allosteric effectors
(14). Another unique property of E. coli UMP
kinase is a very low solubility at neutral pH (<0.1 mg/ml). UTP and/or
alkaline pH increases the solubility of bacterial enzymes up to 50 times (15).
The fact that the pyrH gene product, with no counterpart in
eukarya, is essential for cell growth and division makes it an attractive new target for antibacterial drugs. To properly use this
property of UMP kinase, a number of questions concerning the
architecture and mechanistic features of the protein should be
answered. In the absence of high-resolution three-dimensional data for
UMP kinase, other approaches such as chemical modification or
site-directed mutagenesis in combination with spectroscopic techniques
were considered.
Sequence comparison of E. coli UMP kinase with other known
phosphotransferases allowed identification of a gap-free region (amino
acids 145 to 194) exhibiting 28% identity and 51% similarity with
aspartokinases. Another segment, situated between amino acids 35 and 78 of E. coli UMP kinase, exhibits 30% identity and 64% similarity with phosphoglycerate kinase from Haloarticula
valismortis (Fig. 1). Based on these
alignments, a number of residues of bacterial UMP kinase were selected
for analysis by site-directed mutagenesis. The modified proteins were
overproduced and purified by procedures similar to those used for the
wild-type protein (14). Biochemical, kinetic, and
spectroscopic analysis of the modified proteins revealed a number of
residues essential for catalysis (Asp146), binding of UMP (Asp174), or
interaction with effectors (Arg62 and Asp77). Two other modified forms
of UMP kinase (D201N and D159N), described initially in previous papers
(14, 15), were shown to play a role in the solubility of the
protein at neutral pH.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Alignment of amino acid sequence of UMP kinase (UMPK)
from E. coli with partial sequence of aspartokinase (AK) and
phosphoglycerate kinase (PGK). Identical residues in UMP kinase and in
the other proteins, expressed in one-letter code, are indicated in bold
characters. Amino acid residues submitted to site-directed mutagenesis
(R62H, D77N, D146N, D159N, D168N, D174N, and D201N) are marked by
arrows. Ec, E. coli; Hv, H. valismortis; Sc,
Saccharomyces cerevisiae.
|
|
 |
MATERIALS AND METHODS |
Chemicals.
Nucleotides, restriction enzymes, T4 DNA ligase,
and coupling enzymes were from Boehringer Mannheim. T7 DNA polymerase
and the four deoxynucleoside triphosphates used in sequencing reactions were from Pharmacia. Oligonucleotides were synthesized by the phosphoamidinate method, using a commercial DNA synthesizer (Cyclone; Biosearch). NDP kinase from Dictyostelium discoideum (2,000 U/mg of protein) was kindly provided by M. Véron.
Bacterial strains, plasmids, growth conditions, and DNA
manipulations.
Strain BLI5 (14), used for
overexpression of the pyrH gene, was derived from E. coli BL21(DE3) (Novagen Inc.). The strain expressed the
lacI gene on plasmid pDIA17 (10) and the T7 RNA polymerase gene on the chromosome. Bacteria were grown in 2YT medium
(11) supplemented with ampicillin (100 µg/ml) and
chloramphenicol (30 µg/ml). When the optical density at 600 nm
reached 1.5, 1 mM isopropyl-
-D-thiogalactoside was added
to the medium. The bacteria were harvested by centrifugation 3 h
after induction. Site-directed mutagenesis was performed with the
single-stranded DNA of phagemid pDIA5418 grown in strain CJ236 in the
presence of plasmid pDIA17 and the helper phage M13KO7 (5).
Sequences of oligonucleotides used for mutagenesis are given in Table
1. For each mutagenesis, the whole
sequence of the pyrH gene was checked for the absence of any
other mutation by the dideoxynucleotide sequencing method
(12).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Amino acid substitutions and their consequences on the
solubility and fluorescence properties of E. coli
UMP kinase
|
|
Purification of UMP kinase and activity assay.
Wild-type UMP
kinase and several of the modified variants (D77N, R62H, D146N, D168N,
and D174N) overproduced in the same bacteria were purified as described
previously (14). The D159N and D201N variants were purified
by ion-exchange and gel permeation chromatography (15). The
UMP kinase activity was determined at 30°C and 0.5-ml final volume,
using a coupled spectrophotometric assay (1) with a Beckman
DU640 instrument. The reaction medium buffered with 50 mM Tris-acetate
(pH 6) or with 50 mM Tris-HCl (pH 7.4 or 8) contained 50 mM KCl, 2 mM
MgCl2, 1 mM phosphoenolpyruvate, 0.2 mM NADH, various
concentrations of ATP and UMP, and 2 U each of pyruvate kinase, NDP
kinase, and lactate dehydrogenase. The reaction was started with UMP
kinase. One unit of the enzyme corresponds to 1 µmol of product
formed per min.
Analytical procedures.
Protein concentration was measured by
the method of Bradford (2). Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as
described by Laemmli (6). Fluorescence experiments were
performed on a Shimadzu RF 5001 PC spectrofluorimeter at room
temperature. Binding of UTP to UMP kinase was monitored from the
nucleotide-induced enhancement of the protein fluorescence (14,
15).
 |
RESULTS |
Purification and molecular characterization of the modified forms
of E. coli UMP kinase.
When E. coli
overexpressing the wild-type pyrH gene was disrupted by
sonication in 50 mM Tris-HCl (pH 7.4), over 90% of the enzyme activity
was recovered in the pellet after centrifugation at 10,000 × g (15). The same was true for R62H, D77N, D146N, D168N, and D174N mutants (Table 1). These
modified proteins were solubilized from the bacterial pellet with 100 mM sodium borate (pH 9). Overnight dialysis against 50 mM Tris-HCl (pH
7.4) yielded insoluble recombinant proteins. The precipitates were
washed several times with the same buffer and gave homogeneous enzyme
preparations as determined by SDS-PAGE. The enzymes were stored for
several months at 4°C with no significant loss of activity. An
exception was the D174N mutant, which lost two-thirds of its activity
after 3 months at 4°C. Gel permeation chromatography on Sephacryl
S-300 HR of pure modified enzymes in 50 mM Tris-HCl (pH 8.7) indicated that the active form (over 75% of total protein) corresponds, as in
the case of the wild-type UMP kinase, to the hexamer (molecular mass,
150 ± 10 kDa).
The D159N and D201N mutants exhibited a much higher solubility than the
wild-type protein at neutral pH (Table 1). These variants were purified
by ion-exchange chromatography on DEAE-Sepharose CL-6B, using a linear
gradient from 0 to 0.3 M of NaCl in 50 mM Tris-HCl (pH 7.4) or in 100 mM sodium borate (pH 9). Chromatography on Sephacryl S-300 HR showed
that the active form of the D201N mutant, which exhibited a higher
heterogeneity than expected, was the hexamer. It represented one-third
of the total protein, in mixture with lower- or higher-molecular-mass
oligomers, with no indication of an equilibrium between these forms.
The active form of the D159N mutant represented over 80% of total
protein (15).
Temperature and GdmCl denaturation of UMP kinase mutants.
Wild-type UMP kinase from E. coli showed a high stability
against thermal (melting temperature [Tm] = 63°C) or chemical denaturation (14, 15). The R62H, D146N,
D168N, and D174N mutants were half inactivated at temperatures between
59 and 62°C. Whereas the D159N mutant was particularly resistant
against thermal denaturation (Tm = 73°C), the
D77N and D201N mutants were half inactivated at 52 and 48°C,
respectively. UTP, which at millimolar concentrations increased
substantially the thermal stability of the wild-type enzyme
(15), shifted the Tm of D201N mutant
by almost 30°C. Denaturation of UMP kinase mutants by guanidinium
hydrochloride (GdmCl) was monitored from the red shift of the Trp
fluorescence maximum (15). Most of the variants obtained by
site-directed mutagenesis behaved like the wild-type protein. The
midpoint transition concentration of GdmCl was 1.8 M for the D146N and
D201N mutants, 1.9 M for the wild type and the D77N and D174N mutants,
and 2.0 M for the R62H and D168N mutants.
Kinetic properties of UMP kinase mutants.
Like many regulatory
enzymes, E. coli UMP kinase exhibits a complex kinetic
behavior, which varies with pH (15). At pH 6, the reaction
rates at variable concentrations of one nucleotide in the presence of
several fixed concentrations of cosubstrate yielded intersecting lines
in double-reciprocal plots. Km values for both
ATP and UMP and Vmax values at saturating
concentrations of nucleotides are given in Table
2. ATP over 0.5 mM was inhibitory for the
D77N and D201N variants, an effect independent of the concentration of
Mg2+ ions. The reaction rates fitted by the equation
v = Vmax.
[ATP]/(KmATP + [ATP] + [ATP]2/KI) yielded
KI values for these mutants of 0.64 and 0.94 mM, respectively. The Vmax of the D146N mutant
represented only 0.14% of that of wild-type protein. This mutant was
affected little or not at all in the Km for ATP
and UMP or in its interaction with allosteric effectors, which suggests
that Asp146 is involved primarily in catalysis. The D174N mutant, whose
Vmax represented 30% of that of wild-type
protein, exhibited a 22-fold increase in Km for
UMP. The R62H mutant was affected in Vmax and
Km for both substrates.
When measured at pH 8, the kinetic constants of the wild-type UMP
kinase and those of the site-directed mutants revealed several differences from those determined at pH 6. UMP exerted an inhibitory effect on the wild type and the D146N, D159N, and D168N mutants. The
KI (between 0.4 and 1.2 mM) was calculated by
fitting reaction rates by the equation v = Vmax [UMP]/(KmUMP + [UMP] + [UMP]2/KI). On the other
hand, the relative Vmax values of R62H, D77N, and D201N mutants, compared to that of the parent enzyme, were higher
at alkaline pH than at acidic pH, and the increase of
Km for ATP of the R62H mutant versus that of the
wild-type protein was larger at pH 8 than at pH 6.
The sensitivity of the UMP kinase variants to UTP and GTP was also
examined under different conditions. The effect of these nucleotides on
UMP kinase depends not only on the pH but also on the concentration of
UMP. Thus, at pH 8 and a low (0.1 mM) UMP concentration, the inhibitory
effect of UTP is maximal. On the other hand, the activating effect of
GTP is most visible at the same pH but in the presence of a high (1 mM)
concentration of UMP (15). The wild type and the D159N,
D168N, D174N, and D201N mutants were half inhibited at less than 25 µM UTP, whereas the 50% inhibitory concentration for the D146N
mutant was 40 µM. At these concentrations of nucleotide, the D77N
mutant was fully active and the R62H mutant was only slightly
inhibited. The R62H and D77N mutants were insensitive to the activation
by GTP, whereas the D201N mutant was inhibited by GTP over 0.2 mM. The
other variants of UMP kinase as well as the wild-type enzyme were
activated by GTP by a factor of between 2 and 4 (Fig.
2).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Dependence of the activities of various mutants of
E. coli UMP kinase on UTP (A) and GTP (B). The reaction
medium buffered with Tris-HCl (pH 8) is described in Materials and
Methods. The concentrations of ATP (1 mM) and UMP (0.1 mM [A] and 1 mM [B]) were kept constant; 100% corresponds to the activity of each
mutant in the absence of effectors. , R62H; , D77N; , D146N;
, D159N; , D168N; , D174N; , D201N.
|
|
Fluorescence analysis of UMP kinase variants.
Binding of UTP
to E. coli UMP kinase is a cooperative process. It is
accompanied by a 2.2-fold enhancement in the intrinsic fluorescence of
the wild-type protein (14, 15). The modified forms of UMP
kinase exhibiting sensitivity to inhibition by UTP similar to that of
the wild-type protein behaved very similarly to the parent molecule
with respect to fluorescence. The fluorescence of the R62H mutant was
sensitive to the addition of UTP, but as expected from inhibition
studies, much higher concentrations of nucleotide (>75 µM) were
required to enhance its fluorescence than in the case of the wild-type
enzyme. The D146N variant of UMP kinase exhibited an intrinsic
fluorescence 1.8-fold higher than that of the wild-type protein. The
protein was still sensitive to the addition of UTP, and the overall
increase in fluorescence upon addition of UTP was similar to that of
the wild-type protein. The fluorescence of the D77N mutant was
insensitive to the enhancing effect of UTP in the range of
concentration used in our experiments (Table 1 and Fig.
3).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Fluorescence analysis of the interaction between the
modified forms of UMP kinase and UTP. UMP kinase (1 µM in terms of
monomer) in 50 mM Tris-HCl (pH 7.4) and 100 mM NaCl was titrated at 332 nm (wild type), 333 nm (R62H and D77N), or 334 nm (D168N) with UTP
(between 0.1 and 700 µM). The fluorescence intensity of wild-type UMP
kinase in the absence of UTP was considered 100%.
|
|
 |
DISCUSSION |
UMP kinase from E. coli is in many respects a unique
member of the NMP kinase family. The homohexameric protein, whose
activity is regulated by GTP and UTP, uses UMP as single phosphate
acceptor and ATP or dATP as donors. UMP kinase genes have been
identified by gene sequencing in many other bacteria (Haemophilus
influenzae, Mycobacterium tuberculosis,
Mycoplasma pneumoniae, Chlamydia trachomatis, and
Synechocystis sp.). The E. coli UMP kinase gene
is identical with the smbA gene, originally recognized as
involved in proper chromosomal positioning during cell division
(17). The homology of E. coli UMP kinase with the
pyrH gene product from other organisms or with other
nucleotide binding enzymes served to target the putative catalytic or
regulatory residues. However, conserved and essential residues are not
synonymous, and loss of a specific function by single amino acid
substitution might result from local or propagated conformational
effects. To minimize such undesired effects, the six Asp residues
selected for site-directed mutagenesis were substituted by Asn as the
most conservative replacement with respect to the size and the polar
effect of this side chain. With these inherent limitations of
mutational analysis in mind, we shall concentrate on those results that
help to decipher a protein whose function in the bacterial cell is not
well understood.
(i) From the seven amino acids of UMP kinase substituted by
site-directed mutagenesis, two (D146 and D174) showed significant alteration of a single kinetic parameter, the
Vmax and the KmUMP,
respectively. The activation by GTP or the inhibition by UTP, the
solubility, or the resistance against denaturation of these variants
were similar to that of the wild-type protein. One might therefore
conclude that Asp146 is involved in catalysis, whereas Asp174 is
primarily responsible for binding of UMP. The specific role of these
residues can be tentatively assigned by comparing UMP kinase with
enzymes whose structure in complex with inhibitors, substrates, or
reaction products is known at high resolution (8, 13, 18).
It is conceivable that Asp174 interacts with the hydroxyl group(s) of
the ribose ring in UMP. Similarly, we suppose that Asp146 in UMP
kinase, like Asp84 in E. coli adenylate kinase or Asp89 in
D. discoideum UMP kinase, stabilizes the transition state
(by ca. 3.9 kcal/mol) by interaction with MgATP.
(ii) Although affected in several kinetic parameters, the major
characteristic of D77N and R62H mutants of bacterial UMP kinase is the
loss of activation by GTP and a substantial decrease in affinity for
UTP. For this reason, we assigned Arg62 and Asp77 as regulatory
residues. Their location in the N-terminal third of the polypeptide
chain, far from the catalytic residues Asp146 and Asp174, might
indicate that the regulatory and active sites of UMP kinase belong to
separate domains. Deletion mutagenesis, which might give an answer to
this question, was not conclusive. Even short deletions (up to 25 amino
acid residues) from the N-terminal end of UMP kinase yielded
essentially insoluble and inactive proteins.
(iii) Among E. coli smbA mutants responsible for the altered
morphological phenotype under nonpermissive conditions, cold-sensitive growth, and hypersensitivity to SDS, two resulted from substitution of
Arg62 with His (smbA9) and of Asp201 with Asn
(smbA2) (17). The two modified UMP kinases have
as common properties a low catalytic activity and loss of activation by
GTP. They differ markedly in thermal stability and sensitivity to
inhibition by UTP. Assuming that participation of UMP kinase in cell
proliferation depends solely on its role in the synthesis of UTP, the
relationship between the altered catalytic properties and the
pleiotropic phenotype of smbA2 and smbA9 mutants
is straightforward. As a building block for synthesis of different
forms of RNAs including mRNA or of various uridinyl sugars, UTP is
essential for cell growth and division. This is possibly an
oversimplified view which does not consider the complex structure of
UMP kinase. It is therefore legitimate to hypothesize another function
of the pyrH/smbA gene product, independent of its catalytic
activity. Charlier et al. (3) suggested a direct role of UMP
kinase in the regulation of the upstream, pyrimidine-specific promoter
P1 of the carAB operon. These authors identified a
pyrH mutant in which the modified enzyme (A94E) has a
quasi-normal catalytic activity. Overexpression of the mutant
pyrH allele results in UMP kinase levels that far exceed
that of the wild-type strain but does not restore normal pyridimine-mediated repression.
 |
ACKNOWLEDGMENTS |
We are grateful to H. Sakamoto for valuable help in proposing
several UMP kinase variants, D. Charlier for inspiring discussion, and
M. Ferrand for excellent secretarial assistance. S. Landais is deeply
indebted to J.-C. Mazié for continuous support. N. Bucurenci is
grateful to M. Simionescu for help with spectrofluorimetric experiments.
This work was supported by grants from the Centre National de la
Recherche Scientifique (URA 1129), the Institut Pasteur, France, and
the Ministry for Research and Technology, Romania.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Chimie Structurale des Macromolécules, 28, rue du Docteur Roux,
75724 Paris Cedex 15, France. Phone and fax: 33 (1) 45 68 84 05. E-mail: obarzu{at}pasteur.fr.
 |
REFERENCES |
| 1.
|
Blondin, C.,
L. Serina,
L. Wiesmüller,
A.-M. Gilles, and O. Bârzu.
1994.
Improved spectrophotometric assay of nucleoside monophosphate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system.
Anal. Biochem.
220:219-221[Medline].
|
| 2.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 3.
|
Charlier, D.,
A. Kholti,
M. Gigot,
M. Roovers,
N. Huysveld, and N. Glansdorff.
1996.
p. PS4.4-09..
Abstracts of the 24th FEBS Meeting.
Springer International, Heidelberg, Germany.
|
| 4.
|
Konrad, M.
1992.
Cloning and expression of the essential gene for guanylate kinase from yeast.
J. Biol. Chem.
267:25652-25655[Abstract/Free Full Text].
|
| 5.
|
Kunkel, T. A.,
J. D. Roberts, and R. A. Zakour.
1985.
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Methods Enzymol.
154:367-382.
|
| 6.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 7.
|
Liljelund, P.,
A. Sanni,
J. D. Priesen, and F. Lacroute.
1989.
Primary structure of the S. cerevisiae gene encoding uridine monophosphokinase.
Biochem. Biophys. Res. Commun.
165:464-473[Medline].
|
| 8.
|
Müller, C. W., and G. E. Schulz.
1992.
Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 Å resolution. A model for a catalytic transition state.
J. Mol. Biol.
224:159-177[Medline].
|
| 9.
|
Müller-Dieckmann, H.-J., and G. E. Schulz.
1994.
The structure of uridylate kinase with its substrates, showing the transition state geometry.
J. Mol. Biol.
236:361-367[Medline].
|
| 10.
|
Munier, H.,
A.-M. Gilles,
P. Glaser,
E. Krin,
A. Danchin,
R. S. Sarfati, and O. Bârzu.
1991.
Isolation and characterization of catalytic and calmodulin-binding domains of Bordetella pertussis adenylate cyclase.
Eur. J. Biochem.
196:469-474[Medline].
|
| 11.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 12.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 13.
|
Scheffzek, K.,
W. Kliche,
L. Wiesmüller, and J. Reinstein.
1996.
Crystal structure of the complex of UMP/CMP kinase from Dictyostelium discoideum and the bisubstrate inhibitor P1-(5'-adenosyl)P5-(5'-uridyl) pentaphosphate (UP5A) and Mg2+ at 2.2 Å: implications for water-mediated specificity.
Biochemistry
35:9716-9727[Medline].
|
| 14.
|
Serina, L.,
C. Blondin,
E. Krin,
O. Sismeiro,
A. Danchin,
H. Sakamoto,
A.-M. Gilles, and O. Bârzu.
1995.
Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP.
Biochemistry
34:5066-5074[Medline].
|
| 15.
|
Serina, L.,
N. Bucurenci,
A.-M. Gilles,
W. K. Surewicz,
H. Fabian,
H. H. Mantsch,
M. Takahashi,
I. Petrescu,
G. Batelier, and O. Bârzu.
1996.
Structural properties of UMP-kinase from Escherichia coli: modulation of protein solubility by pH and UTP.
Biochemistry
35:7003-7011[Medline].
|
| 16.
|
Smallshaw, J., and R. A. Kelln.
1992.
Cloning, nucleotide sequence and expression of the Escherichia coli K-12 pyrH gene encoding UMP kinase.
Genetics (Life Sci. Adv.)
11:59-65.
|
| 17.
|
Yamanaka, K.,
T. Ogura,
H. Niki, and S. Hiraga.
1992.
Identification and characterization of the smbA gene, a suppressor of the mukB null mutant of Escherichia coli.
J. Bacteriol.
174:7517-7526[Abstract/Free Full Text].
|
| 18.
|
Yan, H., and M.-D. Tsai.
1991.
Mechanism of adenylate kinase. Demonstration of a functional relationship between aspartate 93 and Mg2+ by site-directed mutagenesis and proton, phosphorus-31 and magnesium-25 NMR.
Biochemistry
30:5539-5546[Medline].
|
J Bacteriol, February 1998, p. 473-477, Vol. 180, No. 3
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lee, S. E., Kim, S. Y., Kim, C. M., Kim, M.-K., Kim, Y. R., Jeong, K., Ryu, H.-J., Lee, Y. S., Chung, S. S., Choy, H. E., Rhee, J. H.
(2007). The pyrH Gene of Vibrio vulnificus Is an Essential In Vivo Survival Factor. Infect. Immun.
75: 2795-2801
[Abstract]
[Full Text]
-
Evrin, C., Straut, M., Slavova-Azmanova, N., Bucurenci, N., Onu, A., Assairi, L., Ionescu, M., Palibroda, N., Barzu, O., Gilles, A.-M.
(2007). Regulatory Mechanisms Differ in UMP Kinases from Gram-negative and Gram-positive Bacteria. J. Biol. Chem.
282: 7242-7253
[Abstract]
[Full Text]
-
Briozzo, P., Evrin, C., Meyer, P., Assairi, L., Joly, N., Barzu, O., Gilles, A.-M.
(2005). Structure of Escherichia coli UMP Kinase Differs from That of Other Nucleoside Monophosphate Kinases and Sheds New Light on Enzyme Regulation. J. Biol. Chem.
280: 25533-25540
[Abstract]
[Full Text]
-
Sakamoto, H., Landais, S., Evrin, C., Laurent-Winter, C., Barzu, O., Kelln, R. A.
(2004). Structure-function relationships of UMP kinases from pyrH mutants of Gram-negative bacteria. Microbiology
150: 2153-2159
[Abstract]
[Full Text]
-
Kim, Y. R., Lee, S. E., Kim, C. M., Kim, S. Y., Shin, E. K., Shin, D. H., Chung, S. S., Choy, H. E., Progulske-Fox, A., Hillman, J. D., Handfield, M., Rhee, J. H.
(2003). Characterization and Pathogenic Significance of Vibrio vulnificus Antigens Preferentially Expressed in Septicemic Patients. Infect. Immun.
71: 5461-5471
[Abstract]
[Full Text]
-
Landais, S., Gounon, P., Laurent-Winter, C., Mazié, J.-C., Danchin, A., Bârzu, O., Sakamoto, H.
(1999). Immunochemical Analysis of UMP Kinase from Escherichia coli. J. Bacteriol.
181: 833-840
[Abstract]
[Full Text]